An antibody for new serological tests
An antibody enabling the development of new medical tests for the diagnosis of SARS-CoV-2 antibodies and other disease related to serological antibodies.
Dextrain obtains the BPI Deep tech label and the French Tech Emergence grant
ARCHOS announces that its Medical Devices Venture subsidiaries, Dextrain and Poladerme, have been awarded the BPI Deep tech label and the French Tech Emergence grant (BFTE).
Availability of a revolutionary early intervention device, helping newborns to crawl
A new baby brand, Daytot, has been created to launch this revolutionary new early intervention device designed to help newborns crawl.
Innovative polymers for membrane protein solubilisation
A co-exclusive license has been signed between Erganeo and companies Polyscope and Cube Biotech for the development and marketing of two versions of polymers that show improved solubilisation efficiencies of membrane proteins.
Erganeo and Emvista sign a license for the use of a unique language resource
In March 2022, Erganeo signed a technology license transfer agreement with Emvista, a software company, concerning a linguistic resource: the French Tree Bank.
Orixha, wins the 2022 innovation award co-organised by Lyonbiopole during Medi’Nov
Orixha, an Erganeo start-up specialising in liquid ventilation technology, has won the Innovation 2022 Prize at the MEDI'NOV trade fair pitch session.
Erganeo is ISO 9001 certified
Erganeo has obtained the certification of its quality management system in accordance with the requirements of the ISO 9001:2015 standard.
Evora Biosciences, Orixha and Icon Photonics among the 100 start-ups to invest in in 2022 (Challenges)
For the thirteenth consecutive year, Challenges has published its selection of "100 start-ups to invest in".
New biomarker for diagnosing triple negative breast cancer
Joint efforts between CliniSciences, Erganeo and the academic lab, in the field of research to facilitate the diagnosis of triple negative breast cancer have yielded new findings that make it easier to classify and predict degree of aggressiveness.
Licensing agreement signed with Hi-Viso Ltd for Crawliskate®
Erganeo signed a licensing agreement with Northern Irish company Hi Viso Ltd for a new device, the Crawliskate®, a piece of ground-breaking technology that helps newborns crawl.